20 Feb 2019 13:43
20 February 2019
NMC Health plc
(the "Company" or "NMC")
Notice of Full Year Results on 7 March 2019
NMC Health plc (LSE: NMC), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 18 countries, will report its full year financial results (for the 12 months to 31 December 2018) on Thursday, 7 March 2019.
The results are expected to be published on the Regulatory News Service of the London Stock Exchange at 7am GMT on 7 March 2019 and shortly thereafter on the Company's website at https://nmc.ae/investor-relations.
Contacts
NMC |
|
Prasanth Manghat, Chief Executive Officer Prashanth Shenoy, Chief Financial Officer Asjad Yahya, Investor Relations | +971 (0)50 522 5648 +971 (0)56 329 0545 +971 (0)56 219 0975 |
Media | |
FTI Consulting, London | |
Brett Pollard / Victoria Foster Mitchell | +44 (0)20 3727 1000 |
FTI Consulting, Gulf | |
Shane Dolan | +971 (0)4 437 2100 |
About NMC Health
NMC the leading private healthcare operator in the GCC with an international network of hospitals across 18 countries. NMC also ranks as one of the top three in-vitro fertilisation ("IVF") operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, the company now has over 34% of its licensed bed capacity in the Kingdom of Saudi Arabia (KSA), where the company has introduced long-term and multi-specialty care services. Moreover, the recent formation of a joint venture with GOSI/Hassana Investment Company is set to substantially boost the Group's bed capacity in KSA, with the JV expected to be the second largest healthcare operator in the Kingdom in terms of number of beds. NMC received over 5.7m patients in 2017. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1.6 billion for the year ended 31 December 2017.
In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.